Victor Golmer
A seasoned pharmaceutical executive from AbbVie (NYSE:ABBV) will soon become the new head of corporate affairs at Novo Nordisk (NVO) as the weight loss drugmaker faces renewed scrutiny from the Trump administration over its drug pricing strategy.
Greg Miley, a